Pharmafocus
Pharmaceutical Industry news, analysis and insights
The biotechnology company foghorn therapeutics has announced the addition of the new chief medical officer, Alfonso Quintás-Cardama, who will be replacing Sam Agresta after his retirement on 11 September 2023.
The Helmholtz Centre for Infection Research (HZI), Germany, has appointed professor Josef Penninger as scientific director.
Cytovation, a clinical stage immune-oncology company with a focus on targeted tumour membrane immunotherapies, has announced that it has appointed Olav Hellebø to its board of directors.
Reacta appoints Kevin Hawkins as new head of regulatory affairs
Immodulon, a late-stage clinical company developing highly differentiated cancer immunotherapies to prime a patient’s own immune system, has announced that it has appointed Dr Josefine Roemmler-Zehrer as chief medical officer.